Advertisement

Ads Placeholder
Loading...

Eli Lilly and Company

LLY•NYSE
Healthcare
Drug Manufacturers - General
$953.30
$22.21(2.39%)
U.S. Market is Open • 10:14

Eli Lilly and Company (LLY) Stock Overview

Explore Eli Lilly and Company’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap900.7B
P/E Ratio41.35
EPS (TTM)$22.90
ROE0.98%
Fundamental Analysis

AI Price Forecasts

1 Month$811.60
3 Months$827.25
1 Year Target$1152.87

LLY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Eli Lilly and Company (LLY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.05, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1152.87.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 41.35 and a market capitalization of 900.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.39%
5-Day Change
2.28%
1-Month Change
-3.74%
3-Month Change
-12.15%
6-Month Change
12.72%
Year-to-Date (YTD) Change
-11.76%
1-Year Change
31.27%
3-Year Change
159.75%
5-Year Change
422.04%
All-Time (Max) Change
33825.27%

Contact Information

https://www.lilly.com
317 276 2000
Lilly Corporate Center, Indianapolis, IN, 46285

Company Facts

470,000 Employees
IPO DateJun 1, 1972
CountryUS
Actively Trading

Frequently Asked Questions